用CCKA受体拮抗剂地伐西匹阻断吗啡位置条件反射。 - Suppr

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

作者信息

Higgins G A, Nguyen P, Sellers E M

机构信息

Clinical Psychopharmacology Program, Addiction Research Foundation, Toronto, Ontario, Canada.

出版信息

Eur J Pharmacol. 1991 May 17;197(2-3):229-30. doi: 10.1016/0014-2999(91)90528-x.

DOI:10.1016/0014-2999(91)90528-x

PMID:1915570

Abstract

摘要

相似文献

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

Eur J Pharmacol. 1991 May 17;197(2-3):229-30. doi: 10.1016/0014-2999(91)90528-x.

Several roles of CCKA and CCKB receptor subtypes in CCK-8-induced and LiCl-induced taste aversion conditioning.

Peptides. 1996;17(3):483-8. doi: 10.1016/0196-9781(96)00028-9.

Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists.

Brain Res. 1992 Feb 14;572(1-2):208-15. doi: 10.1016/0006-8993(92)90471-k.

The CCK-A and CCK-B receptor antagonists, devazepide and L-365,260, enhance morphine antinociception only in non-acclimated rats exposed to a novel environment.

Neuropeptides. 1992 Feb;21(2):119-29. doi: 10.1016/0143-4179(92)90522-x.

Different effects of CCK antagonists on gastric-acid response to CCK and pentagastrin.

Peptides. 1993 Mar-Apr;14(2):253-7. doi: 10.1016/0196-9781(93)90038-i.

The CCKA receptor antagonist devazepide does not modify opioid self-administration or drug discrimination: comparison with the dopamine antagonist haloperidol.

Brain Res. 1994 Mar 21;640(1-2):246-54. doi: 10.1016/0006-8993(94)91880-5.

Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.

Neuroreport. 2000 Mar 20;11(4):829-32. doi: 10.1097/00001756-200003200-00034.

Impairment of stress adaptive behaviours in rats by the CCKA receptor antagonist, devazepide.

Br J Pharmacol. 1996 May;118(2):400-6. doi: 10.1111/j.1476-5381.1996.tb15416.x.

[Potentiation of morphine- and ohmefentanyl-induced analgesia by cholecystokinin receptor antagonists in rat].

Sheng Li Xue Bao. 1993 Jun;45(3):255-61.

[Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].

Sheng Li Xue Bao. 1993 Oct;45(5):470-8.

引用本文的文献

Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction.

Addict Neurosci. 2022 Sep;3. doi: 10.1016/j.addicn.2022.100024. Epub 2022 Jun 17.

Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.

Neurochem Res. 1996 Nov;21(11):1397-410. doi: 10.1007/BF02532381.

Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.

Psychopharmacology (Berl). 1996 Jan;123(2):131-43. doi: 10.1007/BF02246170.

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats.

Psychopharmacology (Berl). 1996 Jan;123(2):119-26. doi: 10.1007/BF02246168.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Blockade of morphine place conditioning by the CCKA receptor antagonist devazepide.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献